PATENT CLAIM ANALYSIS

Application Number: 16066712
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to a tablet comprising candesartan or candesartan cilexetil and amlodipine or its pharmaceutically acceptable salt as active ingredients, the tablet using a particular solubilizer in order to significantly improve the stability and dissolution properties of the active ingredients. In addition, the present invention relates to a method of preparing the tablet.

Claim (Index 6):
The tablet of  claim 5 , wherein the multi-layer tablet is double-layer tablet.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 94.0
- Lexical Diversity: 1.55263
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12740831', '13381534', '13889100', '14240380', '13130294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7206895585080122
- 35 USC 102 Novelty (BERT): 0.5120856296639601
- Combined Prediction Score: 0.699829165623607
- Mean Citation Score: 182.221312
- Max Citation Score: 193.90198
- Similarity Product: 103.29367707132816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test